Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients.
Saved in:
| Title: | Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients. |
|---|---|
| Authors: | Hagemann K; Department of Virus Immunology, Leibniz Institute for Experimental Virology, Hamburg, Germany., Riecken K; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Jung JM; Department of Virus Immunology, Leibniz Institute for Experimental Virology, Hamburg, Germany., Hildebrandt H; Department of Virus Immunology, Leibniz Institute for Experimental Virology, Hamburg, Germany., Menzel S; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Bunders MJ; Department of Virus Immunology, Leibniz Institute for Experimental Virology, Hamburg, Germany.; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Fehse B; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; German Center for Infection Disease (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany., Koch-Nolte F; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Heinrich F; Center for Diagnostics, Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Institute of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Peine S; Institute for Transfusion Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schulze Zur Wiesch J; German Center for Infection Disease (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.; Division of Infectious Diseases, I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Brehm TT; German Center for Infection Disease (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.; Division of Infectious Diseases, I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Addo MM; German Center for Infection Disease (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.; Division of Infectious Diseases, I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department for Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Lütgehetmann M; Center for Diagnostics, Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Altfeld M; Department of Virus Immunology, Leibniz Institute for Experimental Virology, Hamburg, Germany.; German Center for Infection Disease (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany. |
| Source: | European journal of immunology [Eur J Immunol] 2022 Aug; Vol. 52 (8), pp. 1297-1307. Date of Electronic Publication: 2022 Apr 22. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4141 (Electronic) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
